Q18.6
Macrocheilia
Clinical Classification Guidelines
Inclusion Terms
- Hypertrophy of lip, congenital
Medical Intelligence & Overview
Macrocheilia, also known as congenital lip hypertrophy, is a condition characterized by abnormal enlargement of the lips present from birth. This enlargement results from an increase in the volume of lip tissues, primarily affecting the upper or lower lip. While it can be purely cosmetic, severe cases may interfere with eating, speaking, or breathing. Recognizing this condition early helps in planning appropriate management strategies.
Causes & Symptoms
Clinical Causes: Congenital developmental anomaly involving excess tissue growth in the lips Genetic factors contributing to abnormal tissue proliferation Associated syndromes or syndromic conditions that feature lip hypertrophy Unknown precise etiology in some cases, regarded as a developmental malformation
Key Symptoms: Noticeably enlarged or swollen lips present from birth Asymmetry between the lips or facial features Potential difficulty with speech or articulation Challenges with eating or drinking, especially if swelling is significant Possible cosmetic concerns affecting self-esteem In some cases, associated anomalies involving other facial or systemic features
Diagnostic & Treatment
Diagnosis Path: Diagnosis of macrocheilia involves a thorough clinical evaluation by a healthcare provider. The assessment includes examining the lips' size, shape, and symmetry, alongside reviewing the patient’s medical history and any associated conditions. Imaging studies or biopsies are rarely necessary but may be used to rule out other causes such as vascular malformations or neoplasms. Differential diagnoses include inflammatory conditions, vascular malformations, or other congenital syndromes involving lip abnormalities.
Treatment Protocols: Management strategies depend on the severity of lip hypertrophy and associated functional or cosmetic concerns. Options include:
Clinical Advice & FAQs
Billing Guidance
Is Q18.6 a billable ICD-10 code?
Yes, Q18.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q18.6?
Clinical documentation must specify the nature of Macrocheilia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference